Medications for Epilepsy
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Epilepsy.
Found 26 Approved Drugs for Epilepsy
Carbamazepine
Brand Names
Carbatrol, Epitol, Carbamazepin, Tegretol
Carbamazepine
Brand Names
Carbatrol, Epitol, Carbamazepin, Tegretol
Form: Tablet, Suspension, Capsule
Method of administration: Oral
FDA approval date: March 11, 1968
Classification: Mood Stabilizer
Epilepsy Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: Partial seizures with complex symptomatology (psychomotor, temporal lobe). Patients with these seizures appear to show greater improvement than those with other types. Generalized tonic-clonic seizures (grand mal). Mixed seizure patterns which include the above, or other partial or generalized seizures. Absence seizures (petit mal) do not appear to be controlled by carbamazepine. Trigeminal Neuralgia Carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. Beneficial results have also been reported in glossopharyngeal neuralgia. This drug is not a simple analgesic and should not be used for the relief of trivial aches or pains.
Levetiracetam
Brand Names
Spritam, Keppra, Roweepra, Elepsia
Levetiracetam
Brand Names
Spritam, Keppra, Roweepra, Elepsia
Form: Injection, Tablet, Solution
Method of administration: Oral, Intravenous
FDA approval date: April 24, 2000
Primary Generalized Tonic-Clonic Seizures Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults with idiopathic generalized epilepsy. Partial Onset Seizures Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in thetreatment of partial onset seizures in adults with epilepsy. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adult patients (16 years and older) when oral administration is temporarily not feasible. Levetiracetam in Sodium Chloride Injection is an antiepileptic drug indicated for adjuncttherapy in adults (≥16 years of age) with the following seizure types when oraladministration is temporarily not feasible: Partial onset seizures. MyoclonicSeizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults with juvenile myoclonic epilepsy.
LamoTRIgine
Brand Names
Lamictal, Lamictal ODT, Subvenite
LamoTRIgine
Brand Names
Lamictal, Lamictal ODT, Subvenite
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: January 17, 1995
Classification: Anti-epileptic Agent
Lamotrigine is indicated for: Epilepsy — adjunctive therapy in patients aged 2 years and older: Partial-onset seizures. primary generalized tonic-clonic seizures. generalized seizures of Lennox-Gastaut syndrome.
Valproic
Generic Name
Valproic
Valproic
Generic Name
Valproic
Form: Capsule, Solution
Method of administration: Oral
FDA approval date: January 13, 1995
Classification: Anti-epileptic Agent
Valproic Acid Oral Solution is indicated for: Monotherapy and adjunctive therapy of complex partial seizures; sole and adjunctive therapy of simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1 )
Topiramate
Brand Names
Eprontia, Topamax, Trokendi, Qsymia, Qudexy
Topiramate
Brand Names
Eprontia, Topamax, Trokendi, Qsymia, Qudexy
Form: Tablet, Capsule, Solution
Method of administration: Oral
FDA approval date: January 01, 1997
Classification: Sympathomimetic Amine Anorectic
Topiramate tablets are indicated for: Epilepsy: initial monotherapy in patients ≥ 2 years of age with partial onset or primary generalized tonic-clonic seizures.
Showing 1-5 of 26
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances